News
Artificial Sweetener Reduces Response to Immunotherapy
Could artificial sweeteners undo the benefits of immunotherapy? A study published in Cancer Discovery, July 30, found that melanoma and non-small cell lung cancer (NSCLC) patients who consume high levels of the artificial sweetener sucralose have worse responses to immunotherapy…
CancerWorld #108 (October 2025)
CancerWorld is a platform for telling human stories that unfold across science, politics, and society, going beyond the investigation of cancer biology and therapy. In our October 2025 issue, we open with one of two cover stories: the profile of…
Could Radiotherapy Offer Unexpected Protection Against Alzheimer’s Disease?
Women who survive breast cancer may face a surprising advantage: a lower risk of developing Alzheimer’s disease than their peers without cancer. The cohort study, published in JAMA Network Open, 20 June, found that breast cancer survivors had an 8%…
Antidepressants Show Potential to Fight Cancer
Selective serotonin reuptake inhibitors (SSRIs) enhanced the ability of T cells to fight cancer and suppressed tumour growth across a range of cancer types in both mouse and human tumour models. The study, published in Cell, May 20, further showed…
CancerWorld #107 (September 2025)
CancerWorld is not only about cells and treatments. It is about hope, endurance, and the voices that shape the fight against cancer—patients, doctors, scientists, advocates, families, caregivers, and the unsung heroes dedicating their lives to oncology. In this issue, we…
ESO College Voices Contest 2025: Social media – friend or foe for cancer patients? – Winners Announced
This year’s ESO College Voices Contest proved once again that doctors can also be excellent cancer writers. For this year’s contest, we received 27 proposals from ESO College members across 20 countries, each elaborating on the chosen topic: "Social media –…
Six Months of CancerWorld Under p53: A Report of Renewal, Responsibility, and Reach
Dear Readers, Six months ago, we embarked on a journey, ambitious, humbling, and deeply meaningful. In January 2025, CancerWorld, one of Europe’s most prestigious oncology publications, entered a new chapter under the ownership of p53 (OncoDaily). With that acquisition came…
CancerWorld #106 (August 2025)
At CancerWorld, we see cancer care as a meeting point of breakthrough science, human resilience, and the systems that connect them. The August 2025 issue brings that intersection into sharp relief, with a two-sided cover that pairs scientific ingenuity with…
Cancer Neuroscience: How Neurons Fuel Tumor Growth, and What it Means for Therapy
In May 2025, neuroscientist Frank Winkler, together with neurooncologist Michelle Monje, received the Brain Prize for pioneering Cancer Neuroscience, a discipline that explores how neurons actively contribute to tumor growth. How are nerve and tumor cells interacting, and how could…
BRCA1/BRCA2 Mutations Carriers at Greater Risk for Anaplastic Large Cell Lymphoma Associated with Breast Implants
Breast cancer survivors who carry BRCA1 or BRCA2 mutations and received textured implants are 16 times more likely to develop breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) than those who have implants but do not carry these mutations. The study,…